Skip To Content
Fast Forward

For Ayelet Waldman, Microdosing LSD Led to Revelations

Think the psychedelic drug LSD belongs in the tie-dyed “turn on, tune in, drop out” days of the past? Ayelet Waldman — novelist, essayist, and wife of Michael Chabon — believes that, at least when it comes to therapeutic drug use, you ought to think again.

In her new book “A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life,” Waldman details a month she spent using minute doses of LSD to escape an emotional state of, as she told the Forward, “absolute desperation.” During that month, she took 10-microgram doses of the drug — one-fifteenth of an ordinary dose — once every three days.

In “A Really Good Day” Waldman takes an earnest look at her own emotional makeup, the often-surprising science on the use of LSD, opioids, and amphetamines, and the systematic racism of the United States’ War on Drugs.

She didn’t set out to write a book when she began microdosing, she told the Forward. Shortly after she began the experiment, though, she realized its literary potential. The project brought her back in touch with her former career as a federal public defender, during which she often defended clients accused of drug-related felonies.

Stay tuned for a Forward feature on “A Really Good Day.”

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.